menu
    • menu

    Company profile for myTomorrows

    NEW Drugs in Dev: 1
    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    Boai NKY Pharmaceuticals Ltd. is one of the largest global PVP suppliers.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    Nanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.

    Virtual Booth

    Contact Supplier

    Ever Pharma, highly specialized CDMO in producing complex injectables including high potency & controlled substances, suspensions, etc.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    myTomorrows is an independent, globally operating organization based in the Netherlands. We provide patients with unmet medical needs, and their doctors, information about treatment options worldwide and facilitate access to medicines in development. myTomorrows has developed a Knowledge Base to combine vast amounts of medical and clinical data to present an actionable overview of the full clinical development pipeline.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    myTomorrowsNetherlands1 Flag
    Country
    Country
    Netherlands
    Address
    Address
    Anthony Fokkerweg 61, 2 Amsterdam, Noord Holland 1059 CP
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://mytomorrows.com/en/
    Linkedin
    Linkedin
    https://in.linkedin.com/company/mytomorrows
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Rare Disease Research, Mytomorrows Partner On Trial Access
    Rare Disease Research, Mytomorrows Partner On Trial Access

    16 Apr 2026

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/cro/rare-disease-research-and-mytomorrows-partner-rare-disease-clinical-trial-access

    FIERCE BIOTECH
    16 Apr 2026
    Share Share
    Sentynl Selects Mytomorrows To Lead Managed Access Program
    Sentynl Selects Mytomorrows To Lead Managed Access Program

    10 Dec 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/sentynl-selects-mytomorrows-to-lead-managed-access-program-302637819.html

    PR NEWSWIRE
    10 Dec 2025
    Share Share
    myTomorrows Appoints AstraZeneca's Iskra Reic To Board
    myTomorrows Appoints AstraZeneca's Iskra Reic To Board

    31 Jul 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/mytomorrows-appoints-astrazeneca-executive-vice-president-iskra-reic-to-its-board-of-directors-302210950.html

    PR NEWSWIRE
    31 Jul 2024
    Share Share
    Congenica and myTomorrows Announce Partnership
    Congenica and myTomorrows Announce Partnership

    13 Sep 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2023/09/13/2742418/0/en/Congenica-and-myTomorrows-Announce-Partnership-to-Advance-Precision-Oncology-by-Facilitating-Rapid-Access-to-Clinical-Trials.html

    GLOBENEWSWIRE
    13 Sep 2023
    Share Share
    myTomorrows Launches TrialSearch AI to Deliver
    myTomorrows Launches TrialSearch AI to Deliver

    25 Apr 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/04/25/2653623/0/en/myTomorrows-Launches-TrialSearch-AI-to-Deliver-Access-to-Comprehensive-Unbiased-Clinical-Trial-Information-Worldwide.html

    GLOBENEWSWIRE
    25 Apr 2023
    Share Share
    AiCuris collaborates with myTomorrows for an Early Access Program for Pritelivir
    AiCuris collaborates with myTomorrows for an Early Access Program for Pritelivir

    12 Feb 2020

    // ACESS WIRE

    https://finance.yahoo.com/news/aicuris-collaborates-mytomorrows-initiate-early-083500217.html

    ACESS WIRE
    12 Feb 2020
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search